search
Back to results

Fragility Assessment in Adults With ADHD and Mental Retardation (EFAAR)

Primary Purpose

Autism Spectrum Disorder, Mental Retardation

Status
Active
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
ADS severity
Adaptative and intellectual functioning
Psychiatric and somatic comorbidities
Sponsored by
University Hospital, Montpellier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Autism Spectrum Disorder

Eligibility Criteria

20 Years - 95 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ADS diagnosis using DSM-5 or CIM-10 criteria, associated to mental retardation
  • Age over 20 years
  • Patient living in Languedoc-Roussillon's medico-social care home
  • Patient benefiting from social security
  • Patient or legal representative consent collected

Exclusion criteria:

  • Patient or legal representative disagreement to participate at the sudy
  • Pregnant woman or nursong mother
  • Patient with Down syndrom

Sites / Locations

  • CHU Montpellier

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Patients with ADS-MR

Arm Description

Patients presenting Autism Spectrum Disorder and mental retardation who are evaluated for their ADS severity, their adaptative and intellectual functioning, psychiatric and somatic comorbidities

Outcomes

Primary Outcome Measures

Frailty index
this correspond to the frailty cumulative model : 104 clinical and biological criteria are collected. IF = patient criteria (quoted +1 or 0) sum / evaluated criteria total sum

Secondary Outcome Measures

Full Information

First Posted
June 1, 2016
Last Updated
December 27, 2021
Sponsor
University Hospital, Montpellier
search

1. Study Identification

Unique Protocol Identification Number
NCT02791321
Brief Title
Fragility Assessment in Adults With ADHD and Mental Retardation
Acronym
EFAAR
Official Title
Fragility Assessment in Adults With ADHD and Mental Retardation, Advancing Age
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Active, not recruiting
Study Start Date
September 23, 2016 (Actual)
Primary Completion Date
May 2023 (Anticipated)
Study Completion Date
May 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Frailty is a age dependent physiological state of vulnerability. Frailty is screened by the phenotypic model (5 clinical criteria) or the cumulative model (various clinical and biological criteria). Currently, aging with autism spectrum disorder and mental retardation (ADS-MR) is poor described. Nevertheless many data indicate that people with ADS-MR may present an early aging. Principal aim of this study is to determine if frailty in people with ADS-MR aged over 20 years depend on age. Secondary aims are to evaluate frailty prevalence, to describe with details health according to age, and to verify the frailty index validity for predicting falls, hospitalisation and death, in this population of ADS-MR patients aged over 20 years. This monocentric and prospective study will include 60 ADS-MR patients aged over 20 years and living in Languedoc-Roussillon's medico-social care homes. Patients are evaluated at the time of inclusion. Frailty index is calculated from 104 clinical and biological criteria. Furthermore the investigator staff collect data about ADS severity (CARS), adaptative and intellectual functionning (Vineland), and psychiatric and somatic comorbidities (Reiss scale, DSQIID and CIRS). Falls, hospitalisations or death occurrence is then collected every year during 5 years. The connection between frailty index and age will be studied using linear regression. The frailty index validity will be analysed using ROC curves. Modelisation of the falls, hospitalisations or death risk in the 5 years after the initial evaluation will help in identification of the more frailty predictive criteria.
Detailed Description
Calendar : This study will take place during 60 months. 4 first months will be devoted at the ethic and administrative issues. Inclusion will take place during 26 months. Follow-up will take 5 years. Last months will be used for data analysis and articles submission. Perspectives : This study will be the first describing frailty evolution during aging in patients suffering from ADS-MR. It will be useful for creating a new, simple and pragmatical frailty screening tool specific for ADS-MR patients in order to detect earlier which patient are the most frail.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Autism Spectrum Disorder, Mental Retardation

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
63 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Patients with ADS-MR
Arm Type
Other
Arm Description
Patients presenting Autism Spectrum Disorder and mental retardation who are evaluated for their ADS severity, their adaptative and intellectual functioning, psychiatric and somatic comorbidities
Intervention Type
Other
Intervention Name(s)
ADS severity
Intervention Description
Evaluation of the ADS severity with the CARS scale
Intervention Type
Other
Intervention Name(s)
Adaptative and intellectual functioning
Intervention Description
Evaluation with IQ and Vineland II scale
Intervention Type
Other
Intervention Name(s)
Psychiatric and somatic comorbidities
Intervention Description
Evaluation with the Reiss, DSQIID and CIRS Scales
Primary Outcome Measure Information:
Title
Frailty index
Description
this correspond to the frailty cumulative model : 104 clinical and biological criteria are collected. IF = patient criteria (quoted +1 or 0) sum / evaluated criteria total sum
Time Frame
1 day

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
95 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ADS diagnosis using DSM-5 or CIM-10 criteria, associated to mental retardation Age over 20 years Patient living in Languedoc-Roussillon's medico-social care home Patient benefiting from social security Patient or legal representative consent collected Exclusion criteria: Patient or legal representative disagreement to participate at the sudy Pregnant woman or nursong mother Patient with Down syndrom
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amaria BAGHDADLI, PU-PH
Organizational Affiliation
CRA Peyre Plantade - La Colombière - CHU Montpellier
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Montpellier
City
Montpellier
ZIP/Postal Code
34000
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Fragility Assessment in Adults With ADHD and Mental Retardation

We'll reach out to this number within 24 hrs